Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F5RBL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,089
Award facts
- Contract value 100% obligated
- $20,089.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,089.02 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on January 26, 2026, with a completion date of January 27, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and veteran healthcare systems, reflecting the strategic pharmaceutical supply needs of the Department of Defense.
This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen operates as a subsidiary of its parent company, Cencora, Inc. (also doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government agencies. The company's portfolio demonstrates extensive capability in supplying a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5RBL?
SPE2DR26F5RBL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F5RBL worth?
The government has obligated $20,089 on SPE2DR26F5RBL.
Is contract SPE2DR26F5RBL an order under another contract?
Yes. SPE2DR26F5RBL is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RBL competed?
The extent of competition for SPE2DR26F5RBL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award